EP300 and neoplasm: A higher percentage of nuclear NICD (intracellular portions of NOTCH1)-positive cells was observed in tumor samples of CREBBPmut/EP300mut patients than those of CREBBPwt/EP300wt patients (Fig. 3g), confirming the link of CREBBP/EP300 mutations with NOTCH signaling activation.